Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2021

Schedule of Earnings Per Share, Basic and Diluted

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Numerator:
Net loss attributable to Surgery Partners, Inc.	$	(22.9)	$	(61.6)	$	(70.8)	$	(121.6)
Less: amounts allocated to participating securities (1)	—		(10.0)		(10.3)		(29.2)
Net loss attributable to common stockholders	$	(22.9)	$	(71.6)	$	(81.1)	$	(150.8)

Denominator:
Weighted average shares outstanding- basic and diluted (2)	80,726		48,883		68,350		48,736

Loss per share:
Basic and diluted (2)	$	(0.28)	$	(1.46)	$	(1.19)	$	(3.09)

Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
Stock options	1,974		810		1,927		285
Restricted shares	1,461		986		1,444		848

(1)Includes dividends accrued for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.

(2)The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.